Principal Component Analysis (PCA) for RNA-seq: How to Create and Interpret Sample Relationships

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-20

Key Takeaways

• PCA serves as a critical unsupervised diagnostic tool in RNA-seq workflows, typically applied after normalization and before differential expression analysis, to visualize sample relationships and identify potential technical artifacts like batch effects.
• Proper data preprocessing, including filtering low-expression genes and applying variance-stabilizing transformations (e.g., DESeq2's VST or rlog), is essential for PCA to accurately reflect biological variation rather than technical noise or highly expressed genes.
• PCA plots are interpreted by assessing sample clustering by experimental groups, identifying outlier samples that deviate significantly from their expected clusters, and detecting batch effects where samples group by technical origin rather than biological condition.
• Gene loadings on principal components are crucial for biological interpretation, indicating which genes contribute most to sample separation and can guide hypothesis generation about underlying biological mechanisms or responses.
• In single-cell RNA-seq, PCA is a foundational dimensionality reduction step for clustering and visualization, often applied to highly variable genes, though nonlinear methods like UMAP and t-SNE are frequently used subsequently to capture complex cellular structures.
• Reporting the proportion of variance explained by each principal component is vital for contextualizing PCA plots, informing the reader about how much of the total data variation is represented and the potential limitations of interpreting only the first few components.

Principal component analysis (PCA) is a dimensionality reduction method that projects high-dimensional RNA-seq expression data into a small number of principal components capturing the largest sources of variation across samples. For researchers working with bulk or single-cell RNA-seq data, PCA plots serve as a first-line diagnostic tool to assess sample relationships, identify outliers, detect batch effects, and verify that biological groups separate as expected before proceeding to differential expression analysis. This article provides a practical workflow for generating PCA plots in R using ggplot2, interpreting loadings and variance explained, and using PCA results to make informed decisions about data quality and downstream analysis.

The Role of PCA in RNA-seq Analysis Workflows

RNA-seq experiments generate genome-scale expression profiles that can be analyzed through correlation analysis, co-expression analysis, clustering, and differential gene expression studies. The value of RNA-seq data has been confirmed in inferring how gene regulatory systems respond under various conditions in bulk data or across cell types in single-cell data. However, the high dimensionality of these datasets creates challenges for direct visualization and interpretation. PCA addresses this by transforming the original high-dimensional gene expression matrix into a smaller set of uncorrelated principal components that sequentially capture decreasing amounts of variance.

PCA is frequently used in genomics applications for quality assessment and exploratory analysis in high-dimensional data such as RNA-seq gene expression assays. The method serves two primary purposes in a typical RNA-seq workflow. First, it provides an unsupervised view of sample relationships that can reveal whether replicates cluster together, whether experimental groups separate, and whether any samples deviate substantially from expected patterns. Second, PCA results inform decisions about data filtering, batch correction, and whether the experimental design is adequate to answer the biological question at hand.

The placement of PCA within the broader RNA-seq analysis pipeline matters for interpretation. PCA is typically performed after read alignment, quantification, and normalization but before formal differential expression testing. At this stage, the expression matrix contains normalized counts or transformed values for all genes across all samples. The PCA projection uses this matrix to compute sample coordinates in a reduced dimensional space, allowing researchers to visualize the overall structure of the data without imposing any assumptions about group membership.

Core Principles of PCA for Gene Expression Data

PCA operates by finding orthogonal directions in the high-dimensional gene expression space that maximize the variance of the projected data. Each principal component is a linear combination of the original gene expression values, with coefficients called loadings that indicate how much each gene contributes to that component. The first principal component captures the largest amount of variance, the second captures the second largest amount while being orthogonal to the first, and so on.

For RNA-seq data, the input matrix typically has samples as columns and genes as rows, or the transpose depending on the software convention. Before applying PCA, the data should be appropriately transformed and scaled. Raw count data are not suitable for direct PCA because genes with higher overall expression levels dominate the variance calculation. Common preprocessing steps include variance stabilizing transformation from DESeq2, regularized log transformation, or log-transformed counts per million. These transformations stabilize the variance across the dynamic range of expression values and reduce the influence of highly expressed genes.

The number of principal components to examine depends on the data structure and the questions being asked. In practice, the first two or three components are plotted for visualization because they capture the largest sources of variation. However, the proportion of variance explained by each component should be reported, as this informs how much of the total variation is represented in the plot. A plot where the first two components explain only a small fraction of total variance may not reveal meaningful sample separation, even if the data contain strong biological signals distributed across many components.

The interpretation of PCA results relies on the assumption that the largest sources of variation in the data correspond to the biological or technical factors of interest. This assumption can be violated when technical artifacts such as batch effects, library preparation differences, or sequencing depth variation dominate the expression data. In such cases, the first principal components may reflect technical variation instead of biological signal, and the PCA plot will show samples clustering by batch instead of by experimental group.

Preparing RNA-seq Data for PCA

The quality of PCA results depends heavily on the quality of the input data. Before generating PCA plots, researchers should complete several preprocessing steps to ensure that the expression matrix accurately represents the biological signal in the experiment.

Count Matrix Construction and Filtering

The analysis begins with a count matrix where each row represents a gene and each column represents a sample. These counts are generated from alignment and quantification of raw sequencing reads. The choice of alignment and quantification tools affects the count matrix, and different tools may produce slightly different results. Regardless of the tool used, the count matrix should be filtered to remove genes with very low expression across all samples, as these genes contribute noise to the PCA without providing meaningful biological signal.

Filtering thresholds vary by experiment and should be documented in the analysis methods. A common approach is to retain genes that have a minimum number of counts in a minimum number of samples. The specific thresholds depend on sequencing depth and the expected expression levels of biologically relevant genes. The goal is to remove genes that are unlikely to be reliably measured while retaining genes that could distinguish between experimental conditions.

Normalization and Transformation

Normalization is required to make expression values comparable across samples. Different normalization methods exist, including library size normalization, median-of-ratios normalization used by DESeq2, and trimmed mean of M-values normalization used by edgeR. The choice of normalization method can affect PCA results, particularly when samples have substantially different library sizes or composition.

After normalization, the data should be transformed to stabilize variance. For PCA, the variance stabilizing transformation from DESeq2 or the regularized log transformation are commonly used because they produce values that are approximately homoscedastic across the expression range. Log-transformed counts per million can also be used, though this transformation may not fully stabilize variance for low-expression genes.

Scaling Considerations

PCA is sensitive to the scale of the input features. In gene expression analysis, genes are measured on the same scale after transformation, so additional scaling is often not necessary. However, if the input matrix contains features with very different scales, such as when combining expression data with other types of measurements, scaling each feature to unit variance may be appropriate. For standard RNA-seq analysis with transformed count data, scaling by gene is generally not recommended because it can amplify noise from low-expression genes.

Creating PCA Plots in R with ggplot2

The R programming environment provides the tools needed to compute PCA and generate publication-quality plots. The base R function prcomp computes the PCA decomposition, and the ggplot2 package provides flexible plotting capabilities. The workflow described here assumes that the expression data have been prepared as described in the previous section.

Computing the PCA Decomposition

The prcomp function in R performs PCA using singular value decomposition. The input should be a matrix or data frame where rows are genes and columns are samples, with the samples as the observations to be projected. The function centers the data by default, which subtracts the mean of each gene across samples. Scaling can be specified with the scale argument, though this is typically set to FALSE for transformed expression data.

The output of prcomp contains the principal component scores for each sample, the loadings for each gene, and the proportion of variance explained by each component. The scores are stored in the x element of the output object and can be extracted for plotting. The variance explained is computed from the singular values and can be used to annotate plot axes.

Building the Plot Data Frame

To create a PCA plot with ggplot2, the sample scores must be combined with sample metadata into a single data frame. This data frame should contain columns for the principal component scores, sample identifiers, and any grouping variables such as treatment condition, time point, or batch. The grouping variables are used to color points and add ellipses.

The proportion of variance explained by each component should be calculated and stored for use in axis labels. This information helps readers understand how much of the total variation is displayed in the plot. For example, if the first component explains 40 percent of the variance and the second explains 25 percent, the axis labels should indicate these percentages.

Generating the Plot

The ggplot2 code for a PCA plot typically uses geom_point to draw the samples, with the aesthetic mapping specifying the principal component scores on the x and y axes and the grouping variable for point color. Additional layers can add ellipses around groups using stat_ellipse, which draws confidence ellipses based on a multivariate normal assumption.

The plot should include clear axis labels with the component names and variance explained, a legend identifying the groups, and appropriate point styling for readability. For datasets with many samples, point transparency and size adjustments can improve visualization. The final plot should be saved in a vector format such as PDF or SVG for publication use.

At a Glance: PCA Decision Framework for RNA-seq Data

The following table summarizes the key decisions and actions for PCA implementation across different data scenarios.

Interpreting PCA Results for Sample Relationships

The interpretation of PCA plots requires attention to both the overall structure and the specific patterns observed. Several distinct patterns can emerge, each with different implications for downstream analysis.

Expected Clustering by Experimental Group

When the biological signal is strong relative to technical variation, samples from the same experimental group should cluster together in the PCA plot, and different groups should separate along one or more principal components. This pattern confirms that the experimental design captures meaningful biological variation and that the data are suitable for differential expression analysis.

The separation between groups along a particular principal component indicates that the genes with high loadings on that component are driving the difference between groups. Examining these loadings can identify the genes most responsible for group separation, which can inform hypotheses about the biological mechanisms underlying the observed differences.

Outlier Detection

Samples that fall far from their expected group cluster may be outliers. Outliers can arise from sample mislabeling, technical failures during library preparation or sequencing, or genuine biological variation that differs from the rest of the group. The PCA plot provides a visual signal that warrants investigation before proceeding with downstream analysis.

When an outlier is identified, the researcher should examine the sample's quality metrics, including mapping rates, duplication rates, and library complexity. If the outlier appears to be a technical failure, the sample may need to be removed from the analysis or re-sequenced. If the outlier represents genuine biological variation, the researcher must decide whether to retain the sample and account for the variation in the analysis model or exclude it based on predefined criteria.

Batch Effects and Technical Variation

Samples clustering by batch, sequencing run, or other technical factors instead of by experimental group indicate the presence of batch effects. Batch effects can obscure biological signal and lead to false conclusions if not addressed. The PCA plot provides an initial assessment of whether batch effects are present and how strongly they influence the data.

When batch effects are detected, several options exist. The analysis model can include batch as a covariate in the differential expression analysis. Alternatively, batch correction methods can be applied to remove technical variation before downstream analysis. The choice of approach depends on the experimental design and whether batch is confounded with the biological factor of interest.

Continuous Gradients and Unexpected Structure

Sometimes PCA plots reveal continuous gradients or unexpected groupings that do not correspond to the experimental design. These patterns may reflect underlying biological variation such as cell cycle state, differentiation status, or environmental factors that were not controlled in the experiment. The PCA plot serves as a discovery tool that can generate new hypotheses about sources of variation in the data.

Using PCA for Quality Assessment

PCA serves as a quality assessment tool that complements other RNA-seq quality metrics. The gene expression PCA plot provides insights into the association between samples, while additional quality metrics such as transcript integrity number scores provide a quality map of the RNA-seq data. Studies have found that RNA-seq datasets deposited in public repositories often contain a few low-quality samples that can lead to misinterpretations if not identified and addressed.

Sample-Level Quality Assessment

The position of each sample in the PCA plot relative to its expected group provides a visual quality check. Samples that deviate substantially from their group centroid may have quality issues that affect their expression profiles. The PCA plot should be examined alongside other quality metrics such as total read counts, mapping percentages, and gene detection rates to determine whether a deviating sample should be flagged.

Dataset-Level Quality Assessment

The overall structure of the PCA plot provides information about the dataset as a whole. If the first few principal components explain a very small proportion of total variance, the data may be dominated by noise or contain many sources of variation that are not captured by the experimental design. This situation may indicate problems with sample quality, library preparation, or the biological system being studied.

Comparison Across Datasets

PCA can also be used to compare expression patterns across datasets, such as when integrating data from multiple studies or comparing results from different laboratories. Samples from different datasets can be projected into the same PCA space to assess whether they show consistent patterns or whether dataset-specific effects dominate. This approach is particularly useful for meta-analyses and for validating findings across independent cohorts.

Variance Explained and Component Selection

The proportion of variance explained by each principal component provides important context for interpreting PCA plots. This information is typically displayed as a scree plot, which shows the variance explained by each component in decreasing order. The scree plot helps researchers determine how many components capture meaningful variation and how much information is lost by visualizing only the first two or three components.

Interpreting the Scree Plot

A scree plot typically shows a steep decline in variance explained for the first few components followed by a gradual leveling off. The components before the leveling off point are considered to capture meaningful structure, while the remaining components capture progressively smaller amounts of variation that may represent noise. The exact number of meaningful components depends on the data and should be determined based on the specific analysis goals.

Reporting Variance Explained

When presenting PCA results, the variance explained by each plotted component should be reported in the axis labels or figure legend. This information allows readers to assess how much of the total variation is represented in the plot. A plot showing only 20 percent of total variance may not provide a complete picture of sample relationships, even if the visible separation appears clear.

Component Selection for Downstream Analysis

In some workflows, principal components are used as input for downstream analyses such as clustering or batch correction. The number of components selected for these purposes should be based on the variance explained and the biological interpretability of the components. Selecting too few components may discard meaningful signal, while selecting too many may introduce noise.

Examining Gene Loadings for Biological Interpretation

The loadings from PCA indicate how much each gene contributes to each principal component. Genes with large positive or negative loadings on a component are the primary drivers of sample separation along that component. Examining these genes can provide biological insight into the sources of variation captured by the PCA.

Identifying Driver Genes

For a given principal component, the genes with the largest absolute loadings can be extracted and examined. These genes represent the expression programs that distinguish samples along that component. Functional enrichment analysis of these genes can identify biological pathways and processes associated with the observed sample separation.

Connecting Loadings to Experimental Design

The interpretation of loadings should be connected to the experimental design. If samples separate along the first principal component according to treatment condition, the genes with high loadings on that component are likely to be involved in the response to treatment. If separation occurs along the second component according to a different factor, the loadings on that component reflect the genes associated with that factor.

Limitations of Loading Interpretation

The interpretation of loadings has limitations. Each principal component is a linear combination of all genes, and the loadings represent the contribution of each gene to that combination. Genes with high loadings are correlated with the component, but this does not establish causation or identify the specific regulatory mechanisms involved. The loadings provide a starting point for hypothesis generation instead of a definitive biological explanation.

PCA in Single-Cell RNA-seq Analysis

PCA plays a central role in single-cell RNA-seq analysis, where it is used for dimensionality reduction before clustering and visualization. The high noise and high dimensionality of single-cell data make effective dimensionality reduction essential for identifying cell types and subpopulations. PCA is an essential tool for visualizing high-dimensional single-cell data and identifying cell subpopulations.

Preprocessing for Single-cell PCA

Single-cell RNA-seq data require additional preprocessing before PCA compared to bulk RNA-seq data. The data are typically filtered to remove low-quality cells and genes, normalized to account for differences in sequencing depth, and transformed to stabilize variance. Highly variable genes are often selected for PCA because they capture the most biological signal while reducing the influence of technical noise.

PCA as a Step in Single-cell Workflows

In standard single-cell analysis workflows such as those implemented in Seurat, PCA is performed on the scaled expression data of highly variable genes. The principal components are then used as input for clustering algorithms and for downstream visualization methods such as t-SNE and UMAP. The number of principal components used for these downstream steps affects the resolution of the clustering and the separation of cell types in the visualizations.

Limitations of PCA for Single-cell Data

Traditional PCA has limitations when used to mine the nonlinear manifold structure of single-cell data. PCA assumes a linear mapping between the data and the latent components, which may not hold for complex single-cell datasets. The principal components may also be overly dense, meaning that many genes contribute to each component, which reduces interpretability. Alternative methods that incorporate graph regularization or nonlinear transformations have been developed to address these limitations.

Alternative and Complementary Dimensionality Reduction Methods

While PCA is a standard tool for RNA-seq analysis, other dimensionality reduction methods can complement or replace PCA depending on the analysis goals. Each method has different assumptions and produces different visualizations of the data structure.

t-SNE and UMAP for Visualization

t-Distributed Stochastic Neighbor Embedding (t-SNE) is a nonlinear dimensionality reduction technique that is widely used for visualizing single-cell RNA-seq data. Unlike PCA, which preserves global structure, t-SNE focuses on preserving local relationships between data points. This makes t-SNE effective at revealing fine-grained structure such as rare cell populations, but the resulting plots are less interpretable in terms of variance explained and can be sensitive to parameter choices.

Uniform Manifold Approximation and Projection (UMAP) is another nonlinear method that has become standard in single-cell workflows. UMAP often produces more compact clusters than t-SNE and better preserves global structure. Both t-SNE and UMAP are typically applied after PCA in single-cell analysis workflows, with the PCA-reduced data serving as input to the nonlinear methods.

Choosing Between Methods

The choice between PCA and nonlinear methods depends on the analysis goals. PCA is appropriate for quality assessment, identifying major sources of variation, and providing an interpretable low-dimensional representation. Nonlinear methods are better suited for visualizing complex structures and identifying rare subpopulations, particularly in single-cell data. Many workflows use PCA for initial exploration and quality control, then apply nonlinear methods for final visualization.

Integration with Clustering

Dimensionality reduction methods are often combined with clustering algorithms to identify groups of samples or cells with similar expression profiles. PCA-reduced data can serve as input to clustering algorithms, and the resulting clusters can be visualized in the PCA plot. The relationship between PCA structure and clustering results provides a check on the consistency of the analysis.

Reproducibility and Reporting Standards

Reproducibility is a core requirement for RNA-seq analysis, and PCA is no exception. The steps used to generate PCA plots should be documented sufficiently for another researcher to reproduce the results. This documentation should include the software versions, preprocessing steps, parameters, and the exact code used for the analysis.

Documenting the Analysis Environment

The analysis environment should be documented, including the versions of R, Bioconductor packages, and any other software used. Package versions can affect results, and different versions may produce slightly different outputs. Recording the session information ensures that the analysis can be reproduced with the same software environment.

Recording Preprocessing Decisions

All preprocessing decisions should be recorded, including filtering thresholds, normalization methods, and transformation choices. These decisions affect the PCA results and should be justified in the analysis documentation. The rationale for each decision should be stated clearly so that reviewers and readers can assess the appropriateness of the choices.

Sharing Code and Data

The code used to generate PCA plots should be shared alongside the results. Reproducible analysis workflows can be implemented using tools such as R Markdown, which combines code, output, and narrative text in a single document. Public repositories and workflow management systems provide infrastructure for sharing and versioning analysis code.

Common Failure Patterns in PCA Interpretation

Several common mistakes can lead to incorrect interpretation of PCA results. Recognizing these patterns helps researchers avoid drawing erroneous conclusions from their data.

Overinterpreting Small Separations

Small separations between groups in a PCA plot may not be biologically meaningful, particularly when the plotted components explain a small proportion of total variance. The visual distance between groups should be considered in the context of the variance explained and the number of samples. Statistical tests for group separation can provide additional evidence beyond visual inspection.

Ignoring Batch Structure

When batch effects are present, the PCA plot may show samples clustering by batch instead of by experimental group. Ignoring this structure and interpreting the plot as reflecting biological variation can lead to incorrect conclusions. The PCA plot should be examined for any grouping that does not correspond to the experimental design.

Misinterpreting Loadings

The loadings on a principal component indicate the contribution of each gene to that component, but they do not directly indicate which genes are differentially expressed between groups. A gene with a high loading may be correlated with the component without being the primary driver of group differences. Formal differential expression analysis is required to identify genes that differ significantly between groups.

Using Inappropriate Input Data

PCA performed on raw counts or improperly normalized data can produce misleading results. The variance in raw counts is dominated by highly expressed genes, and samples with different library sizes may separate along the first principal component due to technical instead of biological variation. Proper normalization and transformation are essential for meaningful PCA results.

Limitations of PCA for RNA-seq Analysis

PCA has several limitations that researchers should understand when interpreting results. These limitations do not diminish the utility of PCA but define the boundaries of what can be concluded from the analysis.

Linearity Assumption

PCA assumes that the relationships between genes and the latent structure in the data are linear. Biological systems often exhibit nonlinear relationships, and these may not be fully captured by PCA. Nonlinear dimensionality reduction methods can reveal structure that PCA misses, but they introduce their own assumptions and challenges.

Sensitivity to Outliers and Noise

PCA is sensitive to outliers and noise in the data. A single outlier sample can substantially influence the principal components, potentially obscuring the structure of the remaining samples. Robust PCA methods that downweight the influence of outliers are available but are less commonly used in standard RNA-seq workflows.

Interpretation Challenges

The biological interpretation of principal components can be challenging. Each component is a linear combination of thousands of genes, and the biological meaning of the component may not be immediately apparent. Functional enrichment analysis of the top loading genes can aid interpretation, but the results should be considered hypothesis-generating instead of definitive.

Dependence on Preprocessing Choices

PCA results depend on the preprocessing choices made before the analysis. Different normalization methods, filtering thresholds, and transformations can produce different PCA plots. This dependence means that PCA results should be interpreted in the context of the specific preprocessing pipeline used.

Practical Workflow for PCA Implementation

The following workflow provides a structured approach to implementing PCA for RNA-seq data analysis. The steps can be adapted to specific experimental designs and analysis goals.

Step 1: Prepare the Expression Matrix

Construct the count matrix from the alignment and quantification results. Filter low-expression genes using documented thresholds. Apply normalization and transformation to produce values suitable for PCA. Verify that the resulting matrix has the expected dimensions and that sample identifiers match the experimental metadata.

Step 2: Compute the PCA

Use the prcomp function or equivalent to compute the PCA decomposition. Center the data and specify scaling as appropriate for the transformed expression values. Extract the sample scores, gene loadings, and variance explained for each component.

Step 3: Generate the PCA Plot

Create a data frame combining the sample scores with experimental metadata. Generate a scatter plot of the first two principal components using ggplot2. Color points by the grouping variable of interest and add confidence ellipses if appropriate. Label the axes with the component names and the proportion of variance explained.

Step 4: Examine the Results

Inspect the PCA plot for expected clustering, outliers, and unexpected structure. Examine the scree plot to assess how much variance is captured by the plotted components. Identify the genes with the largest loadings on the components of interest and consider their biological relevance.

Step 5: Document and Report

Record all preprocessing steps, parameters, and software versions. Save the PCA plot in a publication-ready format. Report the variance explained by the plotted components and describe the observed sample relationships in the context of the experimental design.

Records and Measurements for PCA Analysis

Maintaining detailed records of the PCA analysis supports reproducibility and facilitates troubleshooting when results are unexpected. The following records should be maintained for each PCA analysis.

Input Data Records

Document the source of the count matrix, including the alignment and quantification tools and versions. Record the filtering thresholds applied and the number of genes retained after filtering. Document the normalization and transformation methods used and the software versions for each step.

Analysis Parameters

Record the parameters used for the PCA computation, including whether the data were centered and scaled. Document the number of principal components computed and the criteria used to determine how many components to examine. Record the random seed if any stochastic steps are involved in the preprocessing.

Output Records

Save the PCA plot in both editable and publication formats. Record the variance explained by each principal component. Save the gene loadings for the components of interest for downstream analysis. Document any samples that were flagged as outliers and the decisions made regarding those samples.

Professional Escalation Criteria

Certain findings from PCA analysis warrant consultation with a bioinformatics specialist or statistician before proceeding with downstream analysis. The following situations should trigger escalation.

Severe Batch Effects

If the PCA plot shows strong clustering by batch or other technical factors that obscures biological signal, consult with a specialist about batch correction options. The choice of correction method depends on the experimental design and the relationship between batch and biological factors.

Unexplained Sample Separation

If samples separate into groups that do not correspond to any recorded experimental factor, investigate potential sources of the separation. This may require reviewing laboratory records, sample processing logs, or sequencing metadata. If the source cannot be identified, consult with a specialist about how to proceed.

Conflicting Quality Metrics

If the PCA plot indicates that a sample is an outlier but other quality metrics appear normal, the discrepancy warrants investigation. The sample may have a subtle technical issue that is not captured by standard quality metrics, or the outlier status may reflect genuine biological variation. Consultation with a specialist can help determine the appropriate course of action.

Analysis Results That Contradict Expectations

If the PCA plot shows no separation between groups that are expected to differ substantially, the experimental design or data quality may be inadequate. This situation may indicate problems with sample collection, RNA extraction, library preparation, or sequencing. Consultation with a specialist can help identify the source of the problem and determine whether the data can be salvaged.

Frequently Asked Questions

What is the purpose of PCA in RNA-seq analysis?

PCA reduces the high-dimensional gene expression data to a small number of principal components that capture the largest sources of variation across samples. This reduction allows researchers to visualize sample relationships, identify outliers and batch effects, and assess whether biological groups separate as expected before proceeding with differential expression analysis. PCA serves as both a quality assessment tool and an exploratory analysis method in RNA-seq workflows.

How many principal components should I examine?

The number of principal components to examine depends on the data structure and the analysis goals. For visualization purposes, the first two or three components are typically plotted because they capture the largest sources of variation. The scree plot, which shows the variance explained by each component, can help determine how many components capture meaningful structure. The proportion of variance explained by the plotted components should be reported so readers can assess how much of the total variation is represented.

What preprocessing is required before performing PCA on RNA-seq data?

Raw count data must be filtered to remove low-expression genes, normalized to account for differences in library size and composition, and transformed to stabilize variance. Common transformations include the variance stabilizing transformation from DESeq2, regularized log transformation, or log-transformed counts per million. PCA performed on raw counts or improperly normalized data can produce misleading results dominated by technical variation.

How do I identify outliers in a PCA plot?

Outliers appear as samples that fall far from their expected group cluster in the PCA plot. When an outlier is identified, examine the sample's quality metrics, including mapping rates, duplication rates, and library complexity. If the outlier appears to be a technical failure, the sample may need to be removed or re-sequenced. If the outlier represents genuine biological variation, decide whether to retain the sample and account for the variation in the analysis model.

What should I do if samples cluster by batch instead of by experimental group?

Samples clustering by batch or other technical factors indicate the presence of batch effects that can obscure biological signal. Options include including batch as a covariate in the differential expression analysis model or applying batch correction methods to remove technical variation before downstream analysis. The choice of approach depends on the experimental design and whether batch is confounded with the biological factor of interest.

How do I interpret the loadings from PCA?

The loadings indicate how much each gene contributes to each principal component. Genes with large positive or negative loadings on a component are the primary drivers of sample separation along that component. Examining these genes and performing functional enrichment analysis can provide biological insight into the sources of variation captured by the PCA. The loadings provide a starting point for hypothesis generation instead of a definitive biological explanation.

Can PCA be used for single-cell RNA-seq data?

PCA is an essential tool for visualizing high-dimensional single-cell RNA-seq data and identifying cell subpopulations. In standard single-cell workflows, PCA is performed on the scaled expression data of highly variable genes, and the principal components are used as input for clustering and downstream visualization methods such as t-SNE and UMAP. Traditional PCA has limitations for single-cell data because it assumes linear relationships and may produce overly dense principal components.

What are the limitations of PCA for RNA-seq analysis?

PCA assumes linear relationships between genes and the latent structure in the data, which may not hold for complex biological systems. PCA is sensitive to outliers and noise, and the results depend on the preprocessing choices made before the analysis. The biological interpretation of principal components can be challenging because each component is a linear combination of thousands of genes. Nonlinear dimensionality reduction methods can complement PCA by revealing structure that PCA misses.

Related Bioinformatics Guides

• RNA-Seq Data Analysis in Galaxy: A User-Friendly Platform
• RNA-Seq Data Analysis Workflow: From Raw Reads to Insights
• RNA-Seq Visualization: Volcano Plots, Heatmaps, and PCA
• Genomic Data Analysis Tools: A Comparative Guide for Researchers
• Lipidomic Analysis: A Beginner's Guide to Workflows and Data Interpretation

Related Clinical & Scientific Guides

• A Practical Guide to Detecting Antimicrobial Resistance Genes in Shotgun Metagenomic Data
• Computational Immunology: Modeling the Immune System
• How to Set Hard Filters for Germline Variant Calling: A Practical Guide to GATK Best Practices

References and Further Reading

• NCBI Data Resources. National Center for Biotechnology Information.
• EMBL-EBI Training. European Bioinformatics Institute.
• Bioconductor. Bioconductor Project.
• Galaxy Training Network. Galaxy Project.
• nf-core Documentation. nf-core.
• The Carpentries Lessons. The Carpentries.
• Integrated single-cell transcriptomic analyses identify a novel lineage plasticity-related cancer cell type involved in prostate cancer progression.. EBioMedicine, 2024.
• IRIS-EDA: An integrated RNA-Seq interpretation system for gene expression data analysis.. PLoS computational biology, 2019.
• Joint L(2,p)-norm and random walk graph constrained PCA for single-cell RNA-seq data.. Computer methods in biomechanics and biomedical engineering, 2024.
• Visualization of Single Cell RNA-Seq Data Using t-SNE in R.. Methods in molecular biology (Clifton, N.J.), 2020.
• A Simple Guideline to Assess the Characteristics of RNA-Seq Data.. BioMed research international, 2018.
• Artificial Intelligence in Ocular Transcriptomics: Applications of Unsupervised and Supervised Learning.. Cells, 2025.
• pcaExplorer: an R/Bioconductor package for interacting with RNA-seq principal components.. BMC bioinformatics, 2019.
• Deterministic column subset selection for single-cell RNA-Seq.. PloS one, 2019.
• Transcriptome-Based Subtype Discovery in Breast Cancer Using Variational Representation Learning. 2026.
• Genetic Relatedness and Heterotic Grouping in MRIZP Elite Maize Inbred Lines Using SNP Markers from 25k SNP Array and RNA-seq Data. 2026.
• Integrated Phenotypic and Transcriptomic Profiling Positions ONC212 as a Lead Imipridone in Androgen-Independent Prostate Cancer Models.. 2026.
• Transcriptomic Traces of Noise Exposure in Hearing Loss and Systematic Identification of Biomarker Candidates at the Molecular Scale.. 2026.
• Extremes on the benign-malignant tumour spectrum: Distinct transcriptomic landscapes between two common canine perianal neoplasms based on the hallmarks of cancer.. 2026.
• Interpretable Factors in scRNA-seq Data with Disentangled Generative Models. International Conferences on Biological Information and Biomedical Engineering, 2020.
• i-IF-Learn: Iterative Feature Selection and Unsupervised Learning for High-Dimensional Complex Data. arXiv.org, 2026.
• RNA sequencing data of human prostate cancer cells treated with androgens. Data in Brief, 2019.

This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.